US Patent Issued to Tayu Huaxia Biotech Medical Group on March 25 for "Anti-PD-1 antibodies, dosages and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,407, issued on March 25, was assigned to Tayu Huaxia Biotech Medical Group Co. Ltd. (Beijing).

"Anti-PD-1 antibodies, dosages and uses thereof" was invented by Lieping Chen (Beijing) and Liqun Luo (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are anti-PD-1 antibodies or fragments thereof. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer, infection or immune disorders are also provided."

The patent was filed on July 19, 2019, under Application No. 17/260,974.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Pars...